Brainsway Ltd..
Medical technology company
- Reports this week
- 0
- Active events
- 1
- Connections
- 30
What's happening
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
Brainsway Ltd. listed its American Depositary Receipts (ADRs) on the Nasdaq stock exchange. Harel Insurance Investments was also involved in a stake purchase.Some support12 reports
-
Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.Some support2 reports
-
Brainsway Ltd. and Boston Scientific operate in the medical device industry.Speculative1 report
-
Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.Some support2 reports
-
Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.Some support4 reports
-
BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.Some support1 report
-
Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.Some support2 reports
-
BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.Some support1 report1 development inside
No events began in the chosen period. Widen it, or reset.
Around Brainsway Ltd. this week
News at the entities that move Brainsway Ltd. most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Brainsway Ltd.
-
Harel Insurance Investments & Financial Services Ltd. TransactionalAxon Enterprise stock is listed on Nasdaq, Harel Insurance increased its stake, and the company filed disclosures with the SEC.Moves Brainsway Ltd.
-
South Carolina StructuralThe Sunbelt Ag Expo is scheduled in Moultrie, Georgia, with participation from South Carolina and North Carolina.Moves Brainsway Ltd.
-
MarketBeat Mentioned togetherTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves Brainsway Ltd.
-
Renaissance Technologies TransactionalXiaomi stock is listed on Nasdaq, and Renaissance Technologies boosted its stake in the company.Moves Brainsway Ltd.
-
Royal Bank of Canada TransactionalMarketBeat is providing average rating data as Royal Bank of Canada issues a price target report regarding ConocoPhillips.Moves Brainsway Ltd.
Connections
The 13 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates Brainsway Ltd., granting it market indications for its products.
-
Harel Insurance Investments & Financial Services Ltd. Transactional
Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Brainsway Ltd. in July 2026.
-
Nasdaq Structural
Brainsway Ltd. maintains a formal ADR listing on the Nasdaq stock exchange.
-
SEC Structural
Brainsway Ltd. must comply with the regulatory requirements and filing mandates of the SEC to operate.
-
SWIFT Operational
SWIFT's financial infrastructure facilitates the acceleration of Brainsway's Deep TMS protocol adoption.
-
Renaissance Technologies Transactional
Renaissance Technologies increased its investment stake in Brainsway Ltd. during Q1.
-
South Carolina Structural
Brainsway Ltd. is gaining favorable policy coverage and benefiting from the regulatory environment of South Carolina.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its investment holdings in Brainsway Ltd.
Show all 13 connections
-
Burlington Shared context
Brainsway Ltd. operates and reports results from the location of Burlington.
-
MarketBeat Mentioned together
MarketBeat provides and hosts stock performance ratings and consensus recommendations for Brainsway Ltd.
-
Jerusalem Shared context
Brainsway Ltd. operates and reports financial results from Jerusalem.
-
North America Shared context
Brainsway Ltd.'s market growth is linked to the regional demand dynamics of North America.
-
TMS Mentioned together
The evidence describes TMS's operations but does not mention or describe any relationship with Brainsway Ltd.
History
Events by the month they beganOctober 2026
1 eventJuly 2026
2 eventsJune 2026
7 events- Brainsway Ltd. is expanding its policy coverage across the U.S. and gaining favorable policy coverage in South Carolina.
- Brainsway Ltd. and Boston Scientific operate in the medical device industry.
- Brainsway Ltd. obtained three FDA-cleared indications for its proprietary Deep TMS platform technology.
- Brainsway Ltd. received upward earnings estimate revisions on August 19, 2025.
- BrainsWay invests in Axis Integrated Mental Health to expand access to care, following previous investments in Stella.
- Brainsway Ltd. secured a strategic investment that is expected to expand its market reach.
- BrainsWay Ltd. provided a strategic investment to Neurolief, which is awaiting FDA approval for its drug Proliv™Rx.